Deborah Knobelman - 03 Jun 2024 Form 4 Insider Report for Kronos Bio, Inc. (KRON)

Role: Chief Financial Officer
Signature: /s/ Allison Frisbee, Attorney-in-Fact
Issuer symbol: KRON
Transactions as of: 03 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 04 Jun 2024, 17:02:06 UTC
Previous filing: 02 Feb 2024
Next filing: 06 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRON	Common Stock	Award	$0	+164,260		$0.000000	164,260	03 Jun 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KRON	Employee Stock Option (Right to Buy)	Award	$0	+246,390		$0.000000	246,390	03 Jun 2024	Common Stock	246,390	$0.7450	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares shall vest and become exercisable on June 3, 2025 and the remaining shares shall vest in 36 equal monthly installments as of the last calendar day of each month thereafter.